- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.07 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x R7S: 6-[(1,3-benzothiazol-6-yl)amino]-4-(cyclopropylamino)-N-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]pyridine-3-carboxamide(Non-covalent)
- 10 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 2 residues within 4Å:- Chain A: G.195, T.197
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:T.197
SO4.4: 4 residues within 4Å:- Chain B: I.248, E.249, Y.275, S.279
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:E.249, B:S.279
SO4.5: 3 residues within 4Å:- Chain B: F.10, H.11, S.12
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:S.12
- Salt bridges: B:H.11
SO4.6: 4 residues within 4Å:- Chain B: K.245, H.283, E.284, K.285
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:E.284, B:K.285
- Salt bridges: B:K.245, B:H.283
SO4.7: 3 residues within 4Å:- Chain B: G.195, T.196, T.197
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:G.195, B:T.197
SO4.9: 3 residues within 4Å:- Chain A: N.52
- Chain C: D.267, S.268
4 PLIP interactions:3 interactions with chain C, 1 interactions with chain A- Hydrogen bonds: C:S.268, C:S.268, C:S.268, A:N.52
SO4.10: 3 residues within 4Å:- Chain C: H.283, E.284, K.285
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:E.284, C:K.285
- Salt bridges: C:H.283
SO4.11: 2 residues within 4Å:- Chain A: H.11
- Chain C: T.303
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:H.11
SO4.13: 3 residues within 4Å:- Chain B: N.52
- Chain D: D.267, S.268
2 PLIP interactions:1 interactions with chain B, 1 interactions with chain D- Hydrogen bonds: B:N.52, D:S.268
SO4.14: 3 residues within 4Å:- Chain D: F.10, H.11, S.12
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:S.12
- Salt bridges: D:H.11
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nair, S. et al., Optimization of Nicotinamides as Potent and Selective IRAK4 Inhibitors with Efficacy in a Murine Model of Psoriasis. Acs Med.Chem.Lett. (2020)
- Release Date
- 2020-06-24
- Peptides
- Interleukin-1 receptor-associated kinase 4: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.07 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x R7S: 6-[(1,3-benzothiazol-6-yl)amino]-4-(cyclopropylamino)-N-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]pyridine-3-carboxamide(Non-covalent)
- 10 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nair, S. et al., Optimization of Nicotinamides as Potent and Selective IRAK4 Inhibitors with Efficacy in a Murine Model of Psoriasis. Acs Med.Chem.Lett. (2020)
- Release Date
- 2020-06-24
- Peptides
- Interleukin-1 receptor-associated kinase 4: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D